bioAffinity Technologies, Inc. (BIAFW)San Antonio, United States | NasdaqCM
0.33 USD
-0.03
(-8.333%) ⇩
(April 17, 2026, 3:56 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 11:46 p.m. EDT
BIAFW is a deteriorating fundamental trap with negative growth, massive cash burn, and worthless dividend potential. Despite a recent tick-up to match the fifty-two-week high, the data shows a stagnant trading range, extreme price-to-book undervaluation due to fundamental failure, and no earnings power. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 15.95 |
| Revenue per Share | 3.58 |
| Beta | -0.82 |
| Profit Margins | -241.96% |
| Website | https://bioaffinitytech.com |
| Attribute | Value |
|---|---|
| Address1 | 3,300 Nacogdoches Road |
| Address2 | Suite 216 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -0.815 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.619 |
| City | San Antonio |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.33 |
| Current Ratio | 2.603 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.33 |
| Day Low | 0.3 |
| Debt To Equity | 15.95 |
| Display Name | bioAffinity |
| Ebitda | -10,067,672 |
| Ebitda Margins | -1.6338401 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.33 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.3 |
| Fifty Two Week Low Change | 0.030000001 |
| Fifty Two Week Low Change Percent | 0.1 |
| Fifty Two Week Range | 0.3 - 0.33 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 4,266,308 |
| Free Cashflow | -4,933,569 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 57 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.31405002 |
| Gross Profits | 1,935,160 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-06-28 |
| Language | en-US |
| Long Business Summary | bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas. |
| Long Name | bioAffinity Technologies, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_423045573 |
| Net Income To Common | -14,909,754 |
| Open | 0.47 |
| Operating Cashflow | -9,328,842 |
| Operating Margins | -1.9694501 |
| Phone | 210 698 5334 |
| Previous Close | 0.36 |
| Price Hint | 4 |
| Price To Book | 0.20382954 |
| Profit Margins | -2.41965 |
| Quick Ratio | 2.406 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.030000001 |
| Regular Market Change Percent | -8.333334 |
| Regular Market Day High | 0.33 |
| Regular Market Day Low | 0.3 |
| Regular Market Day Range | 0.3 - 0.33 |
| Regular Market Open | 0.47 |
| Regular Market Previous Close | 0.36 |
| Regular Market Price | 0.33 |
| Regular Market Time | 1,776,455,810 |
| Regular Market Volume | 250 |
| Return On Assets | -0.75628 |
| Return On Equity | -3.01826 |
| Revenue Growth | -0.278 |
| Revenue Per Share | 3.58 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | bioAffinity Technologies, Inc. |
| Source Interval | 15 |
| State | TX |
| Symbol | BIAFW |
| Total Cash | 6,449,782 |
| Total Cash Per Share | 1.435 |
| Total Debt | 1,160,821 |
| Total Revenue | 6,161,959 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 250 |
| Website | https://bioaffinitytech.com |
| Zip | 78,217 |